This article has been cited by
1Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
Stan J. F. Hartman,Navin P. Boeddha,Ebru Ekinci,Birgit C. P. Koch,Rogier Donders,Jan A. Hazelzet,Gertjan J. Driessen,Saskia N. de Wildt
European Journal of Clinical Microbiology & Infectious Diseases.2019;38(7)1255
2Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations
Heleen Aardema,Wouter Bult,Kai van Hateren,Willem Dieperink,Daan J Touw,Jan-Willem C Alffenaar,Jan G Zijlstra
Journal of Antimicrobial Chemotherapy.2019;38(7)1255
3Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children
Agathe Béranger,Mehdi Oualha,Saïk Urien,Mathieu Genuini,Sylvain Renolleau,Radia Aboura,Déborah Hirt,Claire Heilbronner,Julie Toubiana,Jean-Marc Tréluyer,Sihem Benaboud
Clinical Pharmacokinetics.2018;57(7)867